Rasmus Fuglsang-Nielsen1,2,3, Elin Rakvaag4,5, Bente Langdahl4, Knud Erik Bach Knudsen6, Bolette Hartmann7, Jens Juul Holst7, Kjeld Hermansen4,8, Søren Gregersen4,9. 1. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. rasmusfuglsang@gmail.com. 2. Department of Internal Medicine, Regional Hospital Horsens, Horsens, Denmark. rasmusfuglsang@gmail.com. 3. Steno Diabetes Center Aarhus, Aarhus, Denmark. rasmusfuglsang@gmail.com. 4. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. 5. Clinical Pharmacology, Novo Nordisk A/S, Søborg, Denmark. 6. Department of Animal Science, Aarhus University, Tjele, Denmark. 7. Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. 8. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. 9. Steno Diabetes Center Aarhus, Aarhus, Denmark.
Abstract
BACKGROUND: Recently, we demonstrated that whey protein (WP) combined with low dietary fiber improved lipemia, a risk factor for cardiovascular disease in subjects with abdominal obesity. In the present study, we investigated the effects of intake of WP and dietary fiber from enzyme-treated wheat bran on other metabolic parameters of the metabolic syndrome. METHODS: The study was a 12-week, double-blind, randomized, controlled, parallel intervention study. We randomized 73 subjects with abdominal obesity to 1 of 4 iso-energetic dietary interventions: 60 g per day of either WP hydrolysate or maltodextrin (MD) combined with high-fiber (HiFi; 30 g dietary fiber/day) or low-fiber (LoFi; 10 g dietary fiber/day) cereal products. We assessed changes in insulin sensitivity, gut hormones (GLP-1, GLP-2, GIP, and peptide YY), body composition, 24-h BP, resting energy expenditure and respiratory exchange ratio (RER), and appetite. RESULTS:Sixty-five subjects completed the trial. Subjective hunger ratings were lower after 12 weeks of WP compared with MD, independent of fiber content (P = 0.02). We found no effects on ratings of satiety, fullness or prospective food consumption for either of the interventions. Intake of WP combined with LoFi increased the postprandial peptide YY response. There were no effects of WP or fiber on insulin sensitivity, body composition, energy expenditure, incretins, or 24-h BP. CONCLUSIONS: WP consumption for 12 weeks reduced subjective ratings of hunger in subjects with abdominal obesity. Neither WP nor dietary fiber from wheat bran affected insulin sensitivity, 24-h BP, gut hormone responses, body composition, or energy expenditure compared with MD and low dietary fiber.
RCT Entities:
BACKGROUND: Recently, we demonstrated that whey protein (WP) combined with low dietary fiber improved lipemia, a risk factor for cardiovascular disease in subjects with abdominal obesity. In the present study, we investigated the effects of intake of WP and dietary fiber from enzyme-treated wheat bran on other metabolic parameters of the metabolic syndrome. METHODS: The study was a 12-week, double-blind, randomized, controlled, parallel intervention study. We randomized 73 subjects with abdominal obesity to 1 of 4 iso-energetic dietary interventions: 60 g per day of either WP hydrolysate or maltodextrin (MD) combined with high-fiber (HiFi; 30 g dietary fiber/day) or low-fiber (LoFi; 10 g dietary fiber/day) cereal products. We assessed changes in insulin sensitivity, gut hormones (GLP-1, GLP-2, GIP, and peptide YY), body composition, 24-h BP, resting energy expenditure and respiratory exchange ratio (RER), and appetite. RESULTS: Sixty-five subjects completed the trial. Subjective hunger ratings were lower after 12 weeks of WP compared with MD, independent of fiber content (P = 0.02). We found no effects on ratings of satiety, fullness or prospective food consumption for either of the interventions. Intake of WP combined with LoFi increased the postprandial peptide YY response. There were no effects of WP or fiber on insulin sensitivity, body composition, energy expenditure, incretins, or 24-h BP. CONCLUSIONS: WP consumption for 12 weeks reduced subjective ratings of hunger in subjects with abdominal obesity. Neither WP nor dietary fiber from wheat bran affected insulin sensitivity, 24-h BP, gut hormone responses, body composition, or energy expenditure compared with MD and low dietary fiber.
Authors: P K Newby; Janice Maras; Peter Bakun; Denis Muller; Luigi Ferrucci; Katherine L Tucker Journal: Am J Clin Nutr Date: 2007-12 Impact factor: 7.045
Authors: Nicola M McKeown; James B Meigs; Simin Liu; Edward Saltzman; Peter W F Wilson; Paul F Jacques Journal: Diabetes Care Date: 2004-02 Impact factor: 19.112
Authors: Nicola M McKeown; Makiko Yoshida; M Kyla Shea; Paul F Jacques; Alice H Lichtenstein; Gail Rogers; Sarah L Booth; Edward Saltzman Journal: J Nutr Date: 2009-09-02 Impact factor: 4.798
Authors: David J Baer; Kim S Stote; David R Paul; G Keith Harris; William V Rumpler; Beverly A Clevidence Journal: J Nutr Date: 2011-06-15 Impact factor: 4.798
Authors: Ágnes A Fekete; Carlotta Giromini; Yianna Chatzidiakou; D Ian Givens; Julie A Lovegrove Journal: Am J Clin Nutr Date: 2016-10-26 Impact factor: 7.045
Authors: Karen J Murphy; Georgina E Crichton; Kathryn A Dyer; Alison M Coates; Tahna L Pettman; Catherine Milte; Alicia A Thorp; Narelle M Berry; Jonathan D Buckley; Manny Noakes; Peter R C Howe Journal: Nutrients Date: 2013-11-20 Impact factor: 5.717